Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ROND Capital
Nashville, Tennessee, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
ROND Capital was a Nashville-based private equity firm focused on providing liquidity and growth capital to small and growing businesses. The firm was described as industry-agnostic, with reported interest in sectors including healthcare, technology, business services, and consumer. Available public information indicates that ROND Capital was founded around 2017 and later shut down by early 2019. It does not appear to have operated as a drug developer, biotech company, healthcare services operator, or life sciences platform company. As a result, there is no therapeutic pipeline, clinical stage, or product portfolio associated with the firm.
- Industry
- Investors
Beyond the preview
Go deeper on ROND Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ROND Capital.